Capital International, Inc. Bluebird Bio, Inc. Transaction History

Capital International, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$16.59 - $33.89 $85,488 - $174,635	-5,153 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$27.5 - $37.92 $4,757 - $6,560	173 Added 3.47%	5,153 $223,000
Q3 2020 Nov 13, 2020	BUY	$34.44 - $43.75 $24,142 - $30,668	701 Added 16.38%	4,980 $269,000
Q2 2020 Aug 14, 2020	BUY	$27.12 - $45.97 $79,054 - $134,002	2,915 Added 213.71%	4,279 $261,000
Q1 2020 May 15, 2020	SELL	$26.16 - $63.5 $317,399 - $770,445	-12,133 Reduced 89.89%	1,364 $63,000
Q4 2019 Feb 18, 2020	SELL	$46.96 - $61.67 $16.7 Million - $22 Million	-355,927 Reduced 96.35%	13,497 $1.18 Million
Q3 2019 Nov 14, 2019	BUY	$59.47 - $93.1 $19.8 Million - $31 Million	332,772 Added 907.92%	369,424 $33.9 Million
Q2 2019 Aug 14, 2019	BUY	$75.84 - $105.21 $955,887 - $1.33 Million	12,604 Added 52.41%	36,652 $4.66 Million
Q1 2019 May 15, 2019	BUY	$64.44 - $104.11 $174,696 - $282,242	2,711 Added 12.71%	24,048 $3.78 Million
Q4 2018 Feb 14, 2019	SELL	$59.1 - $93.26 $38,001 - $59,966	-643 Reduced 2.93%	21,337 $2.12 Million
Q3 2018 Nov 14, 2018	BUY	$88.86 - $117.49 $551,376 - $729,025	6,205 Added 39.33%	21,980 $3.21 Million
Q2 2018 Aug 14, 2018	BUY	$99.64 - $127.59 $269,725 - $345,386	2,707 Added 20.71%	15,775 $2.48 Million
Q1 2018 May 15, 2018	BUY	$105.8 - $150.94 $1.38 Million - $1.97 Million	13,068 New	13,068 $2.23 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

Stay updated on Capital International, Inc. with notifications on news.